231 related articles for article (PubMed ID: 27742568)
1. CaMKII as a target for arrhythmia suppression.
Mustroph J; Neef S; Maier LS
Pharmacol Ther; 2017 Aug; 176():22-31. PubMed ID: 27742568
[TBL] [Abstract][Full Text] [Related]
2. Calcium-calmodulin kinase II mediates digitalis-induced arrhythmias.
Gonano LA; Sepúlveda M; Rico Y; Kaetzel M; Valverde CA; Dedman J; Mattiazzi A; Vila Petroff M
Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):947-57. PubMed ID: 22009705
[TBL] [Abstract][Full Text] [Related]
3. Experimental antiarrhythmic targets: CaMKII inhibition - ready for clinical evaluation?
Maier LS
Curr Med Chem; 2014; 21(11):1299-307. PubMed ID: 23862619
[TBL] [Abstract][Full Text] [Related]
4. The Ca-calmodulin dependent kinase II: a promising target for future antiarrhythmic therapies?
Fischer TH; Neef S; Maier LS
J Mol Cell Cardiol; 2013 May; 58():182-7. PubMed ID: 23159442
[TBL] [Abstract][Full Text] [Related]
5. Calmodulin kinase II inhibition limits the pro-arrhythmic Ca2+ waves induced by cAMP-phosphodiesterase inhibitors.
Bobin P; Varin A; Lefebvre F; Fischmeister R; Vandecasteele G; Leroy J
Cardiovasc Res; 2016 May; 110(1):151-61. PubMed ID: 26851245
[TBL] [Abstract][Full Text] [Related]
6. Role of CaMKII in cardiac arrhythmias.
Hund TJ; Mohler PJ
Trends Cardiovasc Med; 2015 Jul; 25(5):392-7. PubMed ID: 25577293
[TBL] [Abstract][Full Text] [Related]
7. Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias.
Swaminathan PD; Purohit A; Hund TJ; Anderson ME
Circ Res; 2012 Jun; 110(12):1661-77. PubMed ID: 22679140
[TBL] [Abstract][Full Text] [Related]
8. Ca(2+) /calmodulin-dependent protein kinase II equally induces sarcoplasmic reticulum Ca(2+) leak in human ischaemic and dilated cardiomyopathy.
Fischer TH; Eiringhaus J; Dybkova N; Förster A; Herting J; Kleinwächter A; Ljubojevic S; Schmitto JD; Streckfuß-Bömeke K; Renner A; Gummert J; Hasenfuss G; Maier LS; Sossalla S
Eur J Heart Fail; 2014 Dec; 16(12):1292-300. PubMed ID: 25201344
[TBL] [Abstract][Full Text] [Related]
9. Ca2+/calmodulin-dependent protein kinase II and protein kinase A differentially regulate sarcoplasmic reticulum Ca2+ leak in human cardiac pathology.
Fischer TH; Herting J; Tirilomis T; Renner A; Neef S; Toischer K; Ellenberger D; Förster A; Schmitto JD; Gummert J; Schöndube FA; Hasenfuss G; Maier LS; Sossalla S
Circulation; 2013 Aug; 128(9):970-81. PubMed ID: 23877259
[TBL] [Abstract][Full Text] [Related]
10. Phospholamban ablation rescues the enhanced propensity to arrhythmias of mice with CaMKII-constitutive phosphorylation of RyR2 at site S2814.
Mazzocchi G; Sommese L; Palomeque J; Felice JI; Di Carlo MN; Fainstein D; Gonzalez P; Contreras P; Skapura D; McCauley MD; Lascano EC; Negroni JA; Kranias EG; Wehrens XH; Valverde CA; Mattiazzi A
J Physiol; 2016 Jun; 594(11):3005-30. PubMed ID: 26695843
[TBL] [Abstract][Full Text] [Related]
11. CaMKII and its role in cardiac arrhythmia.
Erickson JR; Anderson ME
J Cardiovasc Electrophysiol; 2008 Dec; 19(12):1332-6. PubMed ID: 18803570
[TBL] [Abstract][Full Text] [Related]
12. Subcellular mechanisms underlying digitalis-induced arrhythmias: role of calcium/calmodulin-dependent kinase II (CaMKII) in the transition from an inotropic to an arrhythmogenic effect.
Gonano LA; Petroff MV
Heart Lung Circ; 2014 Dec; 23(12):1118-24. PubMed ID: 25201479
[TBL] [Abstract][Full Text] [Related]
13. New therapeutic targets in cardiology: arrhythmias and Ca2+/calmodulin-dependent kinase II (CaMKII).
Rokita AG; Anderson ME
Circulation; 2012 Oct; 126(17):2125-39. PubMed ID: 23091085
[No Abstract] [Full Text] [Related]
14. The promise of CaMKII inhibition for heart disease: preventing heart failure and arrhythmias.
Westenbrink BD; Edwards AG; McCulloch AD; Brown JH
Expert Opin Ther Targets; 2013 Aug; 17(8):889-903. PubMed ID: 23789646
[TBL] [Abstract][Full Text] [Related]
15. Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) in the heart.
Maier LS
Adv Exp Med Biol; 2012; 740():685-702. PubMed ID: 22453965
[TBL] [Abstract][Full Text] [Related]
16. Cardiac calmodulin kinase: a potential target for drug design.
Bányász T; Szentandrássy N; Tóth A; Nánási PP; Magyar J; Chen-Izu Y
Curr Med Chem; 2011; 18(24):3707-13. PubMed ID: 21774758
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic Investigation of the Arrhythmogenic Role of Oxidized CaMKII in the Heart.
Foteinou PT; Greenstein JL; Winslow RL
Biophys J; 2015 Aug; 109(4):838-49. PubMed ID: 26287635
[TBL] [Abstract][Full Text] [Related]
18. Calmodulin kinase signaling in heart: an intriguing candidate target for therapy of myocardial dysfunction and arrhythmias.
Anderson ME
Pharmacol Ther; 2005 Apr; 106(1):39-55. PubMed ID: 15781121
[TBL] [Abstract][Full Text] [Related]
19. Calmodulin kinase II inhibition protects against structural heart disease.
Zhang R; Khoo MS; Wu Y; Yang Y; Grueter CE; Ni G; Price EE; Thiel W; Guatimosim S; Song LS; Madu EC; Shah AN; Vishnivetskaya TA; Atkinson JB; Gurevich VV; Salama G; Lederer WJ; Colbran RJ; Anderson ME
Nat Med; 2005 Apr; 11(4):409-17. PubMed ID: 15793582
[TBL] [Abstract][Full Text] [Related]
20. Calm down when the heart is stressed: Inhibiting calmodulin-dependent protein kinase II for antiarrhythmias.
Duan DD
Trends Cardiovasc Med; 2015 Jul; 25(5):398-400. PubMed ID: 25910598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
